Mira Pharmaceuticals, Common Stock Investor Sentiment
MIRA Stock | 1.15 0.07 5.74% |
About 56% of MIRA Pharmaceuticals,'s investor base is looking to short. The analysis of overall sentiment of trading MIRA Pharmaceuticals, Common stock suggests that many investors are alarmed at this time. The current market sentiment, together with MIRA Pharmaceuticals,'s historical and current headlines, can help investors time the market. In addition, many technical investors use MIRA Pharmaceuticals, stock news signals to limit their universe of possible portfolio assets.
MIRA |
MIRA Pharmaceuticals, Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards MIRA Pharmaceuticals, can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about MIRA Pharmaceuticals, that are available to investors today. That information is available publicly through MIRA media outlets and privately through word of mouth or via MIRA internal channels. However, regardless of the origin, that massive amount of MIRA data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of MIRA Pharmaceuticals, news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of MIRA Pharmaceuticals, relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to MIRA Pharmaceuticals,'s headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive MIRA Pharmaceuticals, alpha.
MIRA Pharmaceuticals, Performance against Dow Jones
Price Growth (%) |
Timeline |
1 | Acquisition by Erez Aminov of 2000 shares of MIRA Pharmaceuticals, at 0.84 subject to Rule 16b-3 | 12/27/2024 |
2 | Rising High Exclusive talk with pharmaceutical development company MIRA - TipRanks | 01/16/2025 |
3 | Acquisition by Erez Aminov of 500000 shares of MIRA Pharmaceuticals, subject to Rule 16b-3 | 02/20/2025 |
4 | EXCLUSIVE MIRA Pharmaceuticals Kick Starts Human Trial In Israel For Ketamir-2 For Neuropathic Pain | 03/04/2025 |
5 | Short Interest in MIRA Pharmaceuticals, Inc. Expands By 20.2 | 03/07/2025 |
6 | MIRA Pharmaceuticals Expands Ketamir-2 Development with Topical Treatment for Localized Neuropathic and Inflammatory Pain | 03/13/2025 |
7 | Xenoblade Chronicles X Definitive Edition Review Theyre Dolls, Not Skells | 03/19/2025 |
8 | MIRA Pharmaceuticals Signs Binding Letter of Intent to Acquire SKNY Pharmaceuticals, Securing a 5 Million Capital Infusion to Advance Weight Loss and Smoking Ce... | 03/24/2025 |
Complementary Tools for MIRA Stock analysis
When running MIRA Pharmaceuticals,'s price analysis, check to measure MIRA Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MIRA Pharmaceuticals, is operating at the current time. Most of MIRA Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of MIRA Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MIRA Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of MIRA Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |